Plain-English translation of NCT07230197 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
Fibromyalgia is a chronic condition that causes widespread pain, fatigue, and sleep problems. This trial is testing whether adding a medication called dexmedetomidine to —a standard fibromyalgia treatment—can reduce pain more effectively than alone. The study will compare how well the two-drug combination works compared to one drug by itself.
, the current main treatment for fibromyalgia, only helps about 25–40% of patients achieve meaningful pain relief, and many people experience side effects. Researchers believe that adding dexmedetomidine, which can improve sleep and may help with pain, could offer better relief without causing too many new problems.
You likely qualify if…
You likely don't qualify if…
You will be randomly assigned to take either alone or combined with dexmedetomidine. You'll take your assigned medication regularly and attend visits where researchers will check how much your pain has improved, how well you're sleeping, and whether you're experiencing any side effects. The study involves about 400 people across multiple medical centers, and you'll be tracked over time to see how the treatment works for you.
AI-generated summary from trial data · Jun 6, 2026 · Not medical advice
China